1. Pelucchi, Sara, Mariani, Raffaella, Calza, Stefano, Specchia, Claudia, Piperno, Alberto. 2012. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients. In Haematologica, 97, 1818-25. doi:10.3324/haematol.2012.062661. https://pubmed.ncbi.nlm.nih.gov/22773607/
2. Qing, Mingjie, Zhou, Jiahao, Chen, Weijian, Cheng, Lijuan. 2021. Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon. In Evidence-based complementary and alternative medicine : eCAM, 2021, 2793222. doi:10.1155/2021/2793222. https://pubmed.ncbi.nlm.nih.gov/34326882/
3. Chen, Rui, Cao, Jianhong, Jiang, Wei, Wang, Shunli, Cheng, Jingxin. 2021. Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer. In Journal of oncology, 2021, 7548406. doi:10.1155/2021/7548406. https://pubmed.ncbi.nlm.nih.gov/34594380/
4. Zhao, Gang, Wang, Qijing, Zhang, Yue, Mo, Chunfen, Lin, Ping. 2023. DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. In Cell death & disease, 14, 1. doi:10.1038/s41419-022-05508-y. https://pubmed.ncbi.nlm.nih.gov/36593242/
5. Hu, Weisheng, Jing, Yuan, Yu, Qingqian, Huang, Ning. 2022. Differential gene screening and bioinformatics analysis of epidermal stem cells and dermal fibroblasts during skin aging. In Scientific reports, 12, 12019. doi:10.1038/s41598-022-16314-z. https://pubmed.ncbi.nlm.nih.gov/35835980/
智鼠故事 
